Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Manufacturing & Bioprocessing
Cell and Gene Manufacturing Approaches and Winning Strategies for Commercialisation and Scale-Up
With a host of factors to consider in cell and gene manufacture, upscaling is still no small task. However, as industry experience accumulates and new technologies arrive on the market, there are an increasing number of options for developers looking to get their therapeutic on the road to the clinic.
Immuno-Oncology
Evaxion Biotech Announce New Source of Immunotherapeutic Targets via AI Platform
ERVs have been strongly associated with overall survival in cancer patients. Evaxion hopes they can act as therapeutic targets for non-responsive immunotherapy patients.
Immunotherapy (Non-Oncology)
Novel Targets and Studies in Immunology and Autoimmunity: Antigen-Specific Immunotherapy and Therapeutic Chaperones
Insights on antigen-specific immunotherapy and the immunomodulatory functions of therapeutic chaperones at Immuno UK 2022.